nicotinamide n-oxide has been researched along with Innate Inflammatory Response in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, W; Li, F; Li, S; Song, X; Wang, Y; Wang, Z; Xiao, J; Ye, C; Zeng, Q; Zheng, K | 1 |
| Cutshall, NS; Ihle, NC; Kucera, KA; Latham, J; Ursino, R | 1 |
2 other study(ies) available for nicotinamide n-oxide and Innate Inflammatory Response
| Article | Year |
|---|---|
Nicotinamide n-Oxide Attenuates HSV-1-Induced Microglial Inflammation through Sirtuin-1/NF-κB Signaling.
Topics: Cytokines; Herpes Simplex; Herpesvirus 1, Human; Humans; Inflammation; Microglia; NF-kappa B; Sirtuin 1 | 2022 |
Nicotinamide N-oxides as CXCR2 antagonists.
Topics: Autoimmune Diseases; Binding Sites; Chemokine CXCL1; Chemokines, CXC; Chemotactic Factors; Chemotaxis; Growth Substances; Humans; Hypersensitivity; Inflammation; Inhibitory Concentration 50; Intercellular Signaling Peptides and Proteins; Interleukin-8; Neutrophils; Niacinamide; Protein Binding; Receptors, Interleukin-8B; Structure-Activity Relationship | 2001 |